Back to News
Market Impact: 0.1

Opium farming in Afghanistan shrank by a fifth in 2025, UN survey finds

TRI
Commodities & Raw MaterialsRegulation & LegislationEconomic DataEmerging MarketsGeopolitics & War
Opium farming in Afghanistan shrank by a fifth in 2025, UN survey finds

Opium poppy cultivation in Afghanistan, historically the world's dominant producer, decreased by 20% this year, with the harvest falling 32% to 296 tons, following the Taliban's 2022 ban. Despite this significant supply reduction, dry opium prices dropped 27% to $570/kg, signaling a fundamental shift in drug market dynamics that may prompt cultivation attempts in other regions. Concurrently, the production of synthetic drugs, particularly methamphetamine, has substantially increased, emerging as the new preferred business model for organized crime due to its production ease and detection difficulty.

Analysis

Afghanistan's opium poppy cultivation area is estimated to have decreased by 20% in 2025 to 10,200 hectares, a substantial reduction from 12,800 hectares in 2024 and significantly below the 232,000 hectares cultivated pre-ban in 2022. This decline, following the Taliban's 2022 narcotics ban, resulted in a 32% reduction in the harvest to 296 tons this year, despite a 19% rebound in 2024. Paradoxically, despite the significant supply contraction, the price for dry opium fell 27% to $570 per kilogram. This counter-intuitive price action suggests a fundamental shift in global illicit drug market dynamics, potentially incentivizing increased opium cultivation attempts in other emerging regions. Concurrently, the production of synthetic drugs, particularly methamphetamine, has surged in Afghanistan since the ban. Organized crime groups are increasingly adopting this as a new business model due to its relative ease of production, greater difficulty in detection, and resilience to climate changes, indicating a structural transformation in illicit drug supply chains.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo